Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2015

Open Access 01-12-2015 | Research article

Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand

Authors: Lisa K. Stamp, Peter T. Chapman, Janine Francis, Lutz Beckert, Christopher Frampton, Richard A. Watts, John L. O’Donnell

Published in: Arthritis Research & Therapy | Issue 1/2015

Login to get access

Abstract

Introduction

Granulomatosis with polyangiitis (GPA) is a rare systemic vasculitis. While aetiology is unknown the prominent respiratory involvement suggests inhaled antigens may be involved. The aim of this study was to identify environmental risk factors associated with GPA in Canterbury, New Zealand.

Methods

A case-controlled study was undertaken. All GPA cases fulfilled American College of Rheumatology (ACR), Chapel Hill Consensus Criteria (CHCC) or the European Medicines Agency (EMA) criteria. Each case was gender matched with four controls - 2 musculoskeletal (osteoarthritis or fracture) and 2 respiratory (asthma or chronic obstructive pulmonary disease). One musculoskeletal control and one respiratory control were age matched with the case at the time of the interview (interview) and the remaining two controls were age matched at the time their case experienced the first symptom of vasculitis (index). A structured questionnaire to assess potential environmental agents was administered without blinding for case/control status. Data were analyzed using conditional logistic regression to allow for the individual matching of cases and controls to assess for association between environmental factors and GPA.

Results

49 cases and 196 controls were recruited. 53 % were male and the mean ± standard deviation (SD) age of the cases was 64.9 ± 12.4 years, interview controls 65.1 ± 12.4.years and index controls 53.9 ± 14.5 years. Any reported exposure to dust (specifically silica and grain dust) was associated with GPA, odds ratio (OR) 3.6 (95 % confidence interval (CI); 1.5–8.3, p = 0.003). Occupation as a farm worker was associated with GPA OR 3.43 (1.5–7.5, p = 0.002). Specific gardening activities were associated with GPA including digging (OR 3.2; 1.4–7.0; p = 0.003), mowing (OR 2.7; 1.3–5.8; p = 0.008) and planting (OR 2.6; 1.2–5.5; p = 0.013).

Conclusion

We have replicated findings from northern hemisphere studies identifying dust exposure as well as farm exposure as risk factors for the development of GPA. We have shown activities associated with exposure to inhaled antigens, in particular those related to farming or gardening activities may increase the risk of GPA.
Literature
1.
go back to reference Mahr A, Neogi T, Merkel P. Epidemiology of Wegener’s granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol. 2006;24:S82–91.PubMed Mahr A, Neogi T, Merkel P. Epidemiology of Wegener’s granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol. 2006;24:S82–91.PubMed
2.
go back to reference O'Donnell J, Stevanovic V, Frampton C, Stamp L, Chapman P. Wegener’s granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Int Med J. 2007;37:242–6.CrossRef O'Donnell J, Stevanovic V, Frampton C, Stamp L, Chapman P. Wegener’s granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Int Med J. 2007;37:242–6.CrossRef
3.
go back to reference Lane S, Watts R, Bentham G, Innes N, Scott D. Are environmental factors important in primary systemic vasculitis? A case-controlled study. Arthritis Rheum. 2003;48:814–23.CrossRefPubMed Lane S, Watts R, Bentham G, Innes N, Scott D. Are environmental factors important in primary systemic vasculitis? A case-controlled study. Arthritis Rheum. 2003;48:814–23.CrossRefPubMed
4.
go back to reference Gibson A, Stamp L, Chapman P, O'Donnell J. The epidemiology of Wegener’s granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology. 2006;45:624–8.CrossRefPubMed Gibson A, Stamp L, Chapman P, O'Donnell J. The epidemiology of Wegener’s granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology. 2006;45:624–8.CrossRefPubMed
5.
go back to reference Leavitt R, Fauci A, Bloch D, Michel B, Hunder G, Arend W, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33:1101–7.CrossRefPubMed Leavitt R, Fauci A, Bloch D, Michel B, Hunder G, Arend W, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33:1101–7.CrossRefPubMed
6.
go back to reference Jennette J, Falk R, Andrassy K, Bacon P, Churg J, Gross W, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.CrossRefPubMed Jennette J, Falk R, Andrassy K, Bacon P, Churg J, Gross W, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.CrossRefPubMed
7.
go back to reference Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222–7.PubMedCentralCrossRefPubMed Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222–7.PubMedCentralCrossRefPubMed
8.
go back to reference Office For National Statistics. Statistics, standard occupational classification, vol. 1 and 2. London: The Stationary Office; 2000. Office For National Statistics. Statistics, standard occupational classification, vol. 1 and 2. London: The Stationary Office; 2000.
9.
go back to reference Duna G, Cotch M, Galperin C, Hossman D, Hoffman G. Wegener’s granulomatosis: role of environmental exposures. Clin Exp Rheumatol. 1998;16:669–74.PubMed Duna G, Cotch M, Galperin C, Hossman D, Hoffman G. Wegener’s granulomatosis: role of environmental exposures. Clin Exp Rheumatol. 1998;16:669–74.PubMed
10.
go back to reference Kain R, Tadema H, McKinney E, Benharkou A, Brandes R, Peschel A, et al. High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis. J Am Soc Nephrol. 2012;23:556–66.PubMedCentralCrossRefPubMed Kain R, Tadema H, McKinney E, Benharkou A, Brandes R, Peschel A, et al. High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis. J Am Soc Nephrol. 2012;23:556–66.PubMedCentralCrossRefPubMed
11.
go back to reference Kain R, Exne M, Brandes R, Ziebermayr R, Cunningham D, Alderson C, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008;14:1088–96.PubMedCentralCrossRefPubMed Kain R, Exne M, Brandes R, Ziebermayr R, Cunningham D, Alderson C, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008;14:1088–96.PubMedCentralCrossRefPubMed
12.
go back to reference Søborg D, Hendriksen N, Kroer N. Occurrence and expression of bacterial human virulence gene homologues in natural soil bacteria. FEMS Microbiol Ecol. 2014;90:520–32.PubMed Søborg D, Hendriksen N, Kroer N. Occurrence and expression of bacterial human virulence gene homologues in natural soil bacteria. FEMS Microbiol Ecol. 2014;90:520–32.PubMed
13.
14.
go back to reference Gómez-Puerta J, Gedmintas L, Costenbader K. The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis. Autoimmunity Rev. 2013;12:1129–35.CrossRef Gómez-Puerta J, Gedmintas L, Costenbader K. The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis. Autoimmunity Rev. 2013;12:1129–35.CrossRef
15.
go back to reference Yahya A, Bengtsson C, Larsson P, Too C, Mustafa A, Abdullah N, et al. Silica exposure is associated with an increased risk of developing ACPA-positive rheumatoid arthritis in an Asian population: evidence from the Malaysian MyEIRA case–control study. Mod Rheumatol. 2014;24:271–4.CrossRefPubMed Yahya A, Bengtsson C, Larsson P, Too C, Mustafa A, Abdullah N, et al. Silica exposure is associated with an increased risk of developing ACPA-positive rheumatoid arthritis in an Asian population: evidence from the Malaysian MyEIRA case–control study. Mod Rheumatol. 2014;24:271–4.CrossRefPubMed
17.
go back to reference Lee S, Matsuzaki H, Kumagai-Takei N, Yoshitome K, Maeda M, Chen Y, et al. Silica exposure and altered regulation of autoimmunity. Environ Health Prev Med. 2014;19:322–9.PubMedCentralCrossRefPubMed Lee S, Matsuzaki H, Kumagai-Takei N, Yoshitome K, Maeda M, Chen Y, et al. Silica exposure and altered regulation of autoimmunity. Environ Health Prev Med. 2014;19:322–9.PubMedCentralCrossRefPubMed
Metadata
Title
Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand
Authors
Lisa K. Stamp
Peter T. Chapman
Janine Francis
Lutz Beckert
Christopher Frampton
Richard A. Watts
John L. O’Donnell
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2015
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-015-0852-6

Other articles of this Issue 1/2015

Arthritis Research & Therapy 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine